Abstract
Background Endoscopic thoracic sympathectomy is the definitive surgical treatment for hyperhidrosis, and a nationwide study suggested that it has been performed in a higher rate than which could have been expected due to climate characteristics, comparing to the national statistics.
Objectives To study the epidemiology of sympathectomy to treat hyperhidrosis in São Paulo, the largest city in the Southeast.
Design and setting population-based cross-sectional study.
Methods data on sympathectomies to treat hyperhidrosis between 2008 and 2018 were assessed from the database of the Municipal Health Secretary of São Paulo, Brazil.
Results 65.29% of the patients were female, 66.2% aged between 20 and 39 years and 37.59% had addresses registered outside São Paulo. 1216 procedures were performed in the city of São Paulo from 2008 to 2018, 78.45% of which in only two public hospitals. The number of procedures significantly declined over the years (p = 0.001). 71.63% of the procedures were associated with 2 to 3 days of hospital stay, only 78 intensive care unit days were billed and we did not observe any intra-hospital death.
Conclusions sympathectomies for the treatment of HH were widely performed in the city of São Paulo (1216 procedures), mainly in young (20 -39 years) and female patients, with more than one third of the patients having addresses registered outside the city. This is a very safe surgery, with low need for intensive care units and no mortality in our series. There was a decreasing trend in the number of surgeries over the years.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Nickolas Stabellini (author) received an undergraduate research scholarship from Institutional Scientific Initiation Scholarship Program (PIBIC). Process number 800996 2018 6, granted by the National Council for Scientific and Technological Development (CNPq), Brazil.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the Ethics Committee of the Hospital Israelita Albert Einstein. Data are anonymous at DATASUS, therefore a waiver of informed consent was requested and granted by our institutional review board (process number 3067 17).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data is publicly available at datasus
http://tabnet.saude.sp.gov.br/deftohtm.exe?tabnet/aih_rd2008.def
